baber/WOPTO huggingface dataset:
Patent NZ-536088-A (NZ)
Title: Homogeneous process for the hydrogenation of carboxylic acids and derivatives thereof
Inventor: KILNER MELVYN
IPC: C07C31/10
Filed: 2003-04-29
Abstract: A homogeneous process for the hydrogenation of carboxylic acids and/or derivatives thereof is described. The process involves the use of a catalyst comprising: (a) ruthenium, rhodium, iron, osmium or palladium; and (b) an organic phosphine. The hydrogenation is carried out in the presence of more than 1% by weight water. The reaction temperature is described to be in the range from about 150oC to about 350oC, and the pressure in the range of from about 250 psig to about 2000 psig.
Patent NZ-536471-A (NZ)
Title: Umbrella supporting device
Inventor: DALTON DEAN
Filed: 2004-11-09
Abstract: A umbrella supporting device 1, for use in association with an umbrella, includes a stay with telescopic sections 3,4, clamp means 10 to lock the stay at a desired length and securing means 8 for attaching the stay to the umbrella.
Patent NZ-537783-A (NZ)
Title: Complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives having antibacterial and antifungal actions
Inventor: WEIDNER MORTEN SLOTH
IPC: A61K8/00
Filed: 2003-06-20
Abstract: Disclosed herein are chemical complexes and pharmaceutical compositions comprising a combination of a fatty acid ester of a polyhydroxyalkane and a pyridine carboxy derivative, fatty acid esters with glycerol and 3-carboxy pyridine derivatives such as niacinamide. Their therapeutic application as agents for suppression of hypersensitivity and inflammatory reactions with additional anti-microbial effects, such as bactericidal or fungicidal actions, is also disclosed herein.
Patent NZ-540235-A (NZ)
Title: Nociceptin analogs for the treatment of pain
Inventor: SUN QUN
IPC: C07D263/58
Filed: 2002-04-18
Abstract: A compound of formula (II) that is useful for modulating a pharmacodynamic response from opioid receptors centrally and/or peripherally is disclosed, wherein: Z, A, B, D, R, R1, R2, Q, and n are as described in the specification. These compounds are suitable for treating chronic and acute pain.
Patent NZ-540643-A (NZ)
Title: 1-N-phenylamino-1H-imidazole derivatives as aromatase inhibitors and pharmaceutical compositions containing them
Inventor: ADJE NATHALIE
IPC: C07D233/54
Filed: 2003-12-15
Abstract: Disclosed herein are imidazole derivatives of the formula (I) in which R1, R2, R3, R4, R5, R6 and n are as defined in the specification. Pharmaceutical compositions containing these derivatives, and to the uses thereof are also disclosed. By virtue of their capability to inhibit aromatase, and thus to exhaust all sources of endogenous estrogens, the compounds of formula (I) can be used alone or in combination with other active ingredients for the treatment or the prevention of any estrogen-dependent disorder or for the management of estrogen-regulated reproductive functions, in humans as well as in wild or domestic animals.
Patent NZ-545677-A (NZ)
Title: Wear assembly
Inventor: CARPENTER CHRISTOPHER M
IPC: E02F9/28
Filed: 2002-07-03
Abstract: A wear assembly for a lip of a bucket comprises an adapter and a wear member. The wear member includes a rearwardly opening socket to receive a nose 18 of the adapter. The socket is defined by converging surfaces adapted to overlie converging walls 24, 26 of the nose 18, side surfaces adapted to overlie sidewalls 28, 30 of the nose 18 and a groove associated with each side surface for receiving rails 35 of the nose 18.
Patent NZ-545744-A (NZ)
Title: High-pressure sterilization to terminally sterilize pharmaceutical preparations and medical products
Inventor: RODRIGUEZ ALFREDO
IPC: A61L2/04
Filed: 2004-09-22
Abstract: A method for sterilizing a dynamic dispersion system is disclosed, wherein the method comprises the steps of: pressurizing a dispersion system of small particles or droplets to a pressure in excess of 0.25 MPa to increase the temperature of the system to a temperature in excess of 100 Deg. C for a period of time sufficient to achieve a sterile system, the dispersion system having micro- or nano-dispersions of small particles or droplets, the small particles or droplets having a stable state and an unstable state; and withdrawing pressure from the dispersion system of small particles or droplets before the particles or droplets reach the unstable state, wherein the particles or droplets comprise (i) a therapeutically active compound and (ii) an excipient, the excipient being associated with the therapeutically active compound, wherein the excipient comprises a surfactant.
Patent NZ-546056-A (NZ)
Title: Methods and apparatus for the reduction of moisture variability in large cheese blocks
Inventor: MEHNERT DAVID W
Filed: 2006-03-22
Abstract: A process for making a block of cheese having reduced moisture variability, includes providing a bulk container having a bottom and sidewalls and introducing cheese curd having an initial temperature of about 60 to 90 degree F into the container to form a cheese curd block. The cheese curd block is then pressed to form a cheese block which is cooled in a controlled manner to a final temperature of less than 45 degree F over a total period of about 7 to about 13 days. The controlled cooling is said to be effective to provide a reduced moisture content variation between a geometric centre and side edges of the final cheese block as compared to a similar cheese block cooled directly to 45 degree F over the total period.
Patent NZ-547554-A (NZ)
Title: Glycopegylated granulocyte colony stimulating factor
Inventor: DEFREES SHAWN
IPC: A61K/
Filed: 2004-12-03
Abstract: Disclosed are conjugates between Granulocyte Colony Stimulating Factor and PEG moieties. The conjugates are linked via an intact glycosyl linking group that is interposed between and covalently attached to the peptide and the modifying group. The conjugates are formed from both glycosylated and unglycosylated peptides by the action of a glycosyltransferase. The glycosyltransferase ligates a modified sugar moiety onto either an amino acid or glycosyl residue on the peptide. Also provided are pharmaceutical formulations including the conjugates. Methods for preparing the conjugates are also within the scope of the invention.
Patent NZ-552465-A (NZ)
Title: Breadmaking methods and products
Inventor: DESBUQUOIS PHILIPPE
IPC: A21D8/06
Filed: 2005-07-05
Abstract: Disclosed is a process for making a frozen, pre-baked dough piece which is able to yield a totally baked bread product within 5 minutes or less. Further disclosed is a bread product obtained by the aforementioned disclosure.
Patent NZ-556313-A (NZ)
Title: Improvements in balls for playing games
Inventor: SAVAGE IAN
IPC: A63B41/08
Filed: 2005-12-07
Abstract: A ball for playing a game, particularly a game involving handling of the ball by players, wherein at least a predominant part of an outer surface 1 of the ball has a plurality of protuberances 2, wherein the protuberances 2 have an outer surface 1 including a zone formed by an angular conjunction between at least two surfaces, characterised in that the bases of the protuberances 2 adjacent the outer surface 1 of the ball have a polygonal plan-form and define generally planar faces which extend away from the outer surface 1 of the ball to an apex.
Patent NZ-560750-A (NZ)
Title: Novel derivatives of phosphinic amino acids, preparation method thereof and pharmaceutical compositions containing same
Inventor: DIVE VINCENT
IPC: A61K31/675
Filed: 2006-02-28
Abstract: Disclosed are compounds of formula (I), wherein the substituents are as defined in the specification, their enantiomers and diastereoisomers, and also addition salts thereof with a pharmaceutically acceptable base, and hydrates and solvates thereof, and processes for their preparation. The compounds are useful for preparing compositions for the treatment of arterial hypertension and complications thereof including pulmonary arterial hypertension, myocardial ischaemia, angina pectoris, cardiac insufficiency, vasculopathies, nephropathies, diabetic retinopathies, atherosclerosis and post-angioplasty restenosis, acute or chronic renal insufficiency, cerebrovascular diseases including stroke and subarachnoid haemorrhage, and peripheral ischaemia.
Patent NZ-561329-A (NZ)
Title: Fruit and/or vegetable derived composition
Inventor: MCARTHUR THOMAS JAMES
IPC: A23L19/00
Filed: 2003-07-22
Abstract: There is provided a composition derived from fruit and/or vegetables comprising at least one fruit and/or vegetable-derived pulp and a mild base, the composition having a pH in the range of about 7.5to 9.5.
Patent NZ-564878-A (NZ)
Title: Method of improving the growth characteristics of soil by introducing exhaust emissions from an internal combustion engine
Inventor: LEWIS GARY
IPC: A01B45/02
Filed: 2006-06-06
Abstract: Disclosed is a method of improving the growth characteristics of soil, the method characterised by the steps of: a) operating an internal combustion engine to produce exhaust emissions; b) incorporating the exhaust emissions into the soil by distributing the exhaust emissions through plastic distribution hoses of an agricultural seeding implement when incorporating the exhaust emissions into the soil; c) cooling the exhaust emissions prior to distributing the exhaust emissions through the plastic distribution hoses; and d) using a computer controller to control a cooling rate of the exhaust emissions responsive to a sensed temperature of the exhaust emissions at the distribution hoses.
Patent NZ-565492-A (NZ)
Title: Systems and methods for separating proteins from connective tissue
Inventor: HULTIN HERBERT O
IPC: A23L13/60
Filed: 2006-06-26
Abstract: Disclosed is a method of separating muscle protein from connective tissue. The disclosed method comprises: a) Reducing the size of the muscle tissue which contains both muscle protein and connective tissue. b) Mixing the muscle tissue with an amount of water to create a first slurry. c) Pumping the first slurry through a first pipe and then through at least one constriction, thus causing the first slurry to accelerate in the direction of the flow of the first slurry such that a substantial fraction of the connective tissue will not tear and a substantial fraction of the muscle protein will tear. d) Separating the muscle protein from the connective tissue using a separation device. e) Solubilising the separated muscle protein in a second slurry by raising or lowering the pH of the second slurry to a point at which at least 75% of the separated muscle protein dissolves. The separated muscle protein produced as a result of steps a)-e) is of sufficiently small size that it can be injected directly into intact muscle foods.
Patent NZ-566517-A (NZ)
Title: Nozzle for extinguishing devices and the like with thermoplastic pad over opening removed at predetermined temperature by pressure of extinguishing agent
Inventor: CANDITO FABIO BRUNO
IPC: A62C37/12
Filed: 2006-08-02
Abstract: A nozzle for extinguishing devices and the like, made of a material with a high heat conductivity coefficient and comprising at least one through opening (2), at least one portion of which is blocked hermetically by at least one pad (3) made of thermoplastic material, the pad (3) being automatically removable, due to the pressure of the extinguishing agent, at a preset temperature, so as to allow the automatic dispensing of the extinguishing agent.
Patent NZ-566751-A (NZ)
Title: Atomising injection nozzle
Inventor: CHAPMAN KELVIN MALCOLM
Filed: 2008-03-18
Abstract: An atomising injection nozzle for creating small droplets from a stream of liquid is disclosed. The nozzle has been designed to operate in conditions where the liquid droplets are required in an environment where the pressure is above atmospheric; in particular, the nozzle is designed especially for injecting resin into a blow-line carrying a high-speed stream of wood- fibre particles for manufacturing fibreboard. However, the nozzle could be used in any application where it is necessary to break up a stream of liquid into small droplets.
Patent NZ-577096-A (NZ)
Title: A composition for treating aids and associated conditions comprising plant extracts
Inventor: ASIEDU WILLIAM
IPC: A61K/
Filed: 2003-09-11
Abstract: Disclosed is the use of a composition in the manufacture of a medicament for the treatment of one or more AIDS-related conditions in an AIDS patient in need thereof. The disclosed composition comprises a mixture of extracts from Alstonia boonei, Cleistopholis patens, Dichapetalum madagascariense, Uvariastrum pierreanum, Strophanthus gratus, Gongronema latifolium and Combretum racemosum; and the AIDS related conditions are weight loss, recurrent fever, chronic diarrhoea, dermatitis, cough and general pain.
Patent NZ-578571-A (NZ)
Title: Uplink power control for lte
Inventor: MALLADI DURGA PRASAD
IPC: H04W52/14
Filed: 2008-02-14
Abstract: A method that facilitates generating power control commands in a wireless communication environment and a wireless communications apparatus that enables yielding power control commands for utilization by access terminals in a wireless communication environment are disclosed. The apparatus comprises means for obtaining uplink transmissions sent from an access terminal at an uplink power level; means for evaluating whether to alter the uplink power level employed by the access terminal; and means for sending power control commands via a layer 1/layer 2 (L1/L2) control information channel used for downlink (DL) assignments and uplink (UL) grants. The power control commands adjust the uplink power level by a specified amount. Also disclosed are a method that facilitates employing power control commands in wireless communication environment and a wireless communications apparatus that enables utilizing power control commands in a wireless communication environment. The apparatus comprises means for sending data upon an uplink at a power level; means for obtaining a power control command via a layer 1/layer 2 (L1/L2) control information channel used for downlink (DL) assignments and uplink (UL) grants; and means for changing the power level for a subsequent data transmission as a function of the power control command.
Patent NZ-579852-A (NZ)
Title: Use of a masked or coated copper salt for the treatment of macular degeneration
Inventor: KIS GEORG LUDWIG
IPC: A23L33/15
Filed: 2008-03-19
Abstract: Disclosed is a composition comprising a capsule and a fill, wherein said fill e.g. vitamin C which comprises calcium ascorbate, vitamin E which comprises alpha tocopheryl acetate, zinc which comprises zinc oxide, an omega 3 fatty acid which comprises Omega-3 acid triglycerides and combinations thereof comprises one or more copper-sensitive compounds and said capsule is formed from digestible capsule material comprising a copper salt e.g. copper gluconate, copper oxide, copper carbonate or copper chloride embedded in said digestible material for treating ocular disease.
Patent NZ-580261-A (NZ)
Title: Cooling of a generator using the corners of a casing to direct air to an internal or external heat exchanger
Inventor: ERIKSEN UFFE
IPC: H02K5/00
Filed: 2009-10-08
Abstract: Arrangement for cooling of an electrical machine is disclosed. The electrical machine comprises a rotor (R) and a stator (C) with an air-gap between. Air is able to circulate around the rotor (R) and stator (C) for cooling-purposes. The rotor (R) and the stator (C) are encapsulated by a shell (S) which is formed to allow the flow of hot air from the rotor (R) and the stator (C) to an external heat-exchanger and back to the rotor (R) and stator (C). The shell (S) includes a number of corners, each corner used to gather the hot air before it is guided to the heat-exchanger. A dedicated corner of the shell is connected so that the hot air is sucked out from the corner and is guided without channels directly to the heat- exchanger.
Patent NZ-582256-A (NZ)
Title: Lysimeter and installation method, with lysimeter typically of H shape so as to be pushed through soil in adjacent channel, and with chamber to be placed under suction
Inventor: EKANAYAKE JAGATH CHANDRALAL
IPC: E02D1/06
Filed: 2011-01-12
Abstract: The invention relates to a lysimeter and to a method of inserting a lysimeter into a position within soil to sample water. The lysimeter is adapted to be inserted into the soil in such a way that the soil above the lysimeter through which water to be sampled drains, is substantially undisturbed prior to and during installation of the lysimeter. This provides a more accurate and representative sampling method. The lysimeter provided is in the form of a channel and is adapted to be pushed laterally into the soil under force with minimal disturbance to the soil above it. The lysimeter also has a drainage cavity to be brought under suction.
Patent NZ-586012-A (NZ)
Title: Antitumoral compounds
Inventor: RODRIGUEZ VICENTE ALBERTO
IPC: C07C235/34
Filed: 2008-12-19
Abstract: Disclosed is a compound of general formula I wherein Y is selected from -CHRay-, -CHRay-CHRby-, -CRay=CRby-, -C=C-, -CHRay-CHRby-CHRcy-, -CHRay-CRby=CRcy-, and -CHRay-C=C-; each Ray, Rby, and Rcy is independently selected from hydrogen, substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C2-C12 alkenyl, and substituted or unsubstituted C2-C12 alkynyl; each R1, R2, R3, R4, and R5 is independently selected from hydrogen, substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C2-C12 alkenyl, and substituted or unsubstituted C2-C12 alkynyl; R6 is selected from NR8R9, and OR10; W is selected from O and NR7; R7 is selected from hydrogen, CORa, COORa, substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C2-C12 alkenyl, and substituted or unsubstituted C2-C12 alkynyl, or R7 and R8 together with the corresponding N atom and C atom to which they are attached may form a substituted or unsubstituted heterocyclic group; R8 is selected from hydrogen, CORa, COORa, substituted or unsubstituted C2-C12 alkenyl, substituted or unsubstituted C2-C12 alkynyl, and substituted or unsubstituted C4-C12 alkenynyl; R10 is selected from hydrogen, substituted or unsubstituted C2-C12 alkenyl, and substituted or unsubstituted C2-C12 alkynyl; each dotted line represents an optional additional bond with the proviso that one or more additional bonds are present, but when a triple bond exists between the C atoms to which R1 and R2 are attached, R1 and R2 are absent, and when a triple bond exists between the C atoms to which R3 and R4 are attached, R3 and R4 are absent; R9 is selected from hydrogen, CORa, COORa, substituted or unsubstituted C2-C12 alkenyl, substituted or unsubstituted C2-C12 alkynyl, and substituted or unsubstituted C4-C12 alkenynyl; each R11, R12, R13, R14, and R15 are independently selected from hydrogen, halogen, ORa, CORa, COORa, OCORa, OCOORa, OCONRaRb, CONRaRb, OS(O)Ra, OSO2Ra, OP(O)(Ra)ORb, OSiRaRbRc, NRaRb, NRaCORb, NRaCONRaRb, NRaS(O)Rb, NRaSO2Rb, NRaC(=NRa)NRaRb, SRa, S(O)Ra, SO2Ra, S(O)NRaRb, SO2NRaRb, S(O)ORa, SO2ORa, substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C2-C12 alkenyl, and substituted or unsubstituted C2-C12 alkynyl; and each Ra, Rb, and Rc are independently selected from hydrogen, substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C2-C12 alkenyl, substituted or unsubstituted C2-C12 alkynyl, substituted or unsubstituted aryl and substituted or unsubstituted heterocyclic group; or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof.
Patent NZ-587376-A (NZ)
Title: Methods for the treatment and prevention of age-related retinal dysfunction
Inventor: MAEDA TADAO
IPC: A61K31/07
Filed: 2009-02-10
Abstract: The disclosure relates to the use of a synthetic retinal derivative for the preparation of a medicament for the treatment or prevention of age-related retinal dysfunction in a subject, wherein said medicament is for administration to said subject intermittently about once a month over a period of at least four months, wherein said synthetic retinal derivative is a 9-cis-retinyl ester of formula (l) or an 11-cis-retinyl ester of formula (II), wherein A in each formula is CH2OR and R forms said retinyl ester, and the ester substituent of said synthetic retinal derivative comprises a carboxylate radical of a C1-C10 monocarboxylic acid or a C2-C22 polycarboxylic acid.
Patent NZ-587719-A (NZ)
Title: Fused heterocyclic derivative and use thereof
Inventor: FUJII NOBUHIRO
IPC: A61K31/437
Filed: 2009-02-25
Abstract: Disclosed is a fused heterocyclic compound of formula (I) or a salt thereof, wherein the substituents are as described within the specification. An example of a compound of formula (I) includes N-[1-(2-hydroxyethyl)piperidin-4-yl]-3-methoxy-1-methyl-4-oxo-5-(2-oxo-2-phenylethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]quinoline-2-carboxamide. Further disclosed is a pharmaceutical agent comprising a compound of formula (I), a method of inhibiting Smo or prophylaxis or treatment of cancer in a non-human animal, and the use of a compound of formula (I) for the production of an Smo inhibitor or an agent for the prophylaxis or treatment of cancer.
Patent NZ-588058-A (NZ)
Title: Use of clay slurries for inhibiting the deposition of organic contaminants in pulp and papermaking applications
Inventor: ZHANG FUSHAN
IPC: C08L29/04
Filed: 2009-03-13
Abstract: Disclosed herein is an aqueous slurry composition comprising: (a) at least one clay or clay-like material selected from the group consisting of talc, pyrophyllite, kaolinite, bentonite, montmorillonite, attapulgite, sepiolite, wollastonite and mixtures thereof; (b) at least one nonionic hydrophobically associative polymer selected from the group consisting of hydrophobically modified cellulose ether, hydrophobically modified poly[ethylene glycol], copolymers of vinyl alcohol and vinyl alkonate, hydrophobically modified ethoxylated urethane, hydrophobically modified poly(acetal-polyethers), and mixtures thereof; and (c) optionally, at least one surfactant; wherein the ratio of nonionic hydrophobically associative polymer to clay or clay-like material is from 0.1-10 parts by weight non-ionic hydrophobically associative polymer to 100 parts clay or clay-like material,wherein the clay or clay-like material is present in the composition in an amount of from 20 to 65% by weight, and wherein the clay-like material, preferably is talc having a mean particle size in the range of 0.5 micron to 20 microns.
Patent NZ-588778-A (NZ)
Title: Methanol carbonylation system having absorber with multiple solvent options
Inventor: ZINOBILE RAYMOND J
IPC: B01J8/00
Filed: 2009-04-23
Abstract: A process for making acetic acid using two different scrubber solvents in a common scrubber tower and recycling the used scrubber fluid to the carbonylation process is disclosed, wherein the process comprises the steps of: (a) feeding vent gas from the carbonylation unit to the absorber tower, the vent gas including methyl iodide and optionally additional volatile components;(b) supplying a first scrubber solvent to the absorber tower, the first scrubber solvent consisting essentially of acetic acid;(c) contacting the vent gas with the first scrubber solvent thereby removing methyl iodide and optionally additional volatile components from the gas and absorbing methyl iodide and optionally additional volatile components into the first scrubber solvent; (d) feeding an absorber return stream including first scrubber solvent and absorbed methyl iodide and optionally additional absorbed volatile components to the light ends column and/or dehydration column;(e) terminating the supply of first scrubber solvent to the absorber tower;(f) supplying a second scrubber solvent to the absorber tower, the second scrubber solvent comprising methanol, methyl acetate or mixtures thereof;(g) contacting the vent gas with the second scrubber solvent thereby removing methyl iodide and optionally additional volatile components from the gas and absorbing methyl iodide and optionally additional volatile components into the second scrubber solvent; and (h) feeding an absorber return stream including second scrubber solvent and absorbed methyl iodide and optionally additional absorbed volatile components to the reactor.